A Multicenter Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer
The goal of the study is to test a particular combination of drugs and determine their ability to completely eliminate head and neck cancer.
Head and Neck
DRUG: Hydroxyurea|DRUG: 5- Fluorouracil|DRUG: Cisplatin
Response Rates, To evaluate the activity of 5 cycles of C-FHX/G-CSF in previously untreated patients with stage II and IV locoregionally advanced head and neck cancer., 2-5 years
Feasibility of administering adjuvant CRA and interferon alfa2a, To determine the feasibility of administering adjuvant CRA and interferon alfa2a for up to one or until tumor progression in patients completing local therapy., 2-5 years|Side effects of study regimen, To determine the pattern and degree of clinical toxicity of this regimen, 2-5 years
The goal of the study is to test a particular combination of drugs and determine their ability to completely eliminate head and neck cancer.